JOINN was Successfully Listed on the Hong Kong Stock Exchange 2021-02-26 Prev: JOINN’s Clinical Team Participated in the Clinical Trials of Highlypathogenic Coronavirus N Protein Next: JOINN Laboratories and Nexelis sign Letter of Intent entering partnership to support international sponsors in China in the bioanalytical field
